355 related articles for article (PubMed ID: 31026283)
21. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor.
Singh NP; Hegde VL; Hofseth LJ; Nagarkatti M; Nagarkatti P
Mol Pharmacol; 2007 Dec; 72(6):1508-21. PubMed ID: 17872969
[TBL] [Abstract][Full Text] [Related]
23. ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
Aggelakopoulou M; Kourepini E; Paschalidis N; Panoutsakopoulou V
J Immunol; 2016 Jun; 196(12):4947-56. PubMed ID: 27183630
[TBL] [Abstract][Full Text] [Related]
24. The emerging roles of AhR in physiology and immunity.
Hao N; Whitelaw ML
Biochem Pharmacol; 2013 Sep; 86(5):561-70. PubMed ID: 23856287
[TBL] [Abstract][Full Text] [Related]
25. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
26. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.
Rothhammer V; Mascanfroni ID; Bunse L; Takenaka MC; Kenison JE; Mayo L; Chao CC; Patel B; Yan R; Blain M; Alvarez JI; Kébir H; Anandasabapathy N; Izquierdo G; Jung S; Obholzer N; Pochet N; Clish CB; Prinz M; Prat A; Antel J; Quintana FJ
Nat Med; 2016 Jun; 22(6):586-97. PubMed ID: 27158906
[TBL] [Abstract][Full Text] [Related]
27. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
28. Ambient urban dust particulate matter reduces pathologic T cells in the CNS and severity of EAE.
O'Driscoll CA; Owens LA; Hoffmann EJ; Gallo ME; Afrazi A; Han M; Fechner JH; Schauer JJ; Bradfield CA; Mezrich JD
Environ Res; 2019 Jan; 168():178-192. PubMed ID: 30316103
[TBL] [Abstract][Full Text] [Related]
29. Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo.
Duarte JH; Di Meglio P; Hirota K; Ahlfors H; Stockinger B
PLoS One; 2013; 8(11):e79819. PubMed ID: 24244565
[TBL] [Abstract][Full Text] [Related]
30. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
31. Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells.
Hanieh H; Mohafez O; Hairul-Islam VI; Alzahrani A; Bani Ismail M; Thirugnanasambantham K
PLoS One; 2016; 11(12):e0167650. PubMed ID: 27907195
[TBL] [Abstract][Full Text] [Related]
32. DIM mitigates the development of experimental autoimmune encephalomyelitis by maintaining the stability and suppressive function of regulatory T cells.
Yang S; Tan L; Chen Y; Liu A; Hong M; Peng Z
Cell Immunol; 2020 Dec; 358():104238. PubMed ID: 33137648
[TBL] [Abstract][Full Text] [Related]
33. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
34. miR-155-3p Drives the Development of Autoimmune Demyelination by Regulation of Heat Shock Protein 40.
Mycko MP; Cichalewska M; Cwiklinska H; Selmaj KW
J Neurosci; 2015 Dec; 35(50):16504-15. PubMed ID: 26674874
[TBL] [Abstract][Full Text] [Related]
35. Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR-124 and miR-155 in Experimental Autoimmune Encephalomyelitis.
Zha Z; Gao YF; Ji J; Sun YQ; Li JL; Qi F; Zhang N; Jin LY; Xue B; Yang T; Fan YP; Zhao H; Wang L
Oxid Med Cell Longev; 2021; 2021():5521503. PubMed ID: 33815654
[TBL] [Abstract][Full Text] [Related]
36. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
37. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
38. The roles of aryl hydrocarbon receptor in immune responses.
Nguyen NT; Hanieh H; Nakahama T; Kishimoto T
Int Immunol; 2013 Jun; 25(6):335-43. PubMed ID: 23580432
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
[TBL] [Abstract][Full Text] [Related]
40. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
